Vikas Madan

9PUBLICATIONS
33CO-AUTHORS
Molecular targetsHaematological tumoursMedical infection agents (incl. prions)Epigenetics (incl. genome methylation and epigenomics)Genome structure and regulation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jan 13, 2023
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy.

Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun

|Oct 07, 2021
Sex-Biased ZRSR2 Mutations in Myeloid Malignancies Impair Plasmacytoid Dendritic Cell Activation and Apoptosis.

Katsuhiro Togami, Sun Sook Chung, Vikas Madan

|Nov 05, 2019
Distinct and convergent consequences of splice factor mutations in myelodysplastic syndromes.

Vikas Madan, Jia Li, Siqin Zhou

|Oct 09, 2019
Identification of somatic alterations in lipoma using whole exome sequencing.

Deepika Kanojia, Pushkar Dakle, Anand Mayakonda

|Mar 13, 2019
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice.

Lin Han, Vikas Madan, Anand Mayakonda

|Jul 08, 2018
ARID1A and CEBPα cooperatively inhibit UCA1 transcription in breast cancer.

Xiao Guo, Yin Zhang, Anand Mayakonda

Pageof 2